Efficacy and safety of 2 doses of antenatal dexamethasone in preterm births: addressing methodological concerns

Simple item page
dc.contributor.authorChawanpaiboon S.
dc.contributor.authorChukaew R.
dc.contributor.authorPooliam J.
dc.contributor.correspondenceChawanpaiboon S.
dc.contributor.otherMahidol University
dc.date.accessioned2024-07-31T18:09:38Z
dc.date.available2024-07-31T18:09:38Z
dc.date.issued2024-01-01
dc.identifier.citationAmerican Journal of Obstetrics and Gynecology (2024)
dc.identifier.doi10.1016/j.ajog.2024.06.023
dc.identifier.eissn10976868
dc.identifier.issn00029378
dc.identifier.pmid38908649
dc.identifier.scopus2-s2.0-85199445444
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/100071
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleEfficacy and safety of 2 doses of antenatal dexamethasone in preterm births: addressing methodological concerns
dc.typeLetter
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85199445444&origin=inward
oaire.citation.titleAmerican Journal of Obstetrics and Gynecology
oairecerif.author.affiliationSiriraj Hospital

Files

Collections

Scopus 2024